Activation of SRC, one of the non-receptor tyrosine kinase protein family, promotes cell survival, proliferation, and invasion in various human malignancies including lung, colon, and prostate cancer (Dehm and Bonham, 2004). This evidence concerns the gene SRC and prostate carcinoma.